Home › Peanut Hypersensitivity › Massachusetts › Boston
Peanut Hypersensitivity clinical trials in Boston, MA
6 studies for Peanut Hypersensitivity are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
RecruitingPhase 2
- Massachusetts General Hospital: Department of Medicine: Allergy & Clinical Immunology Unit, Boston
- Boston Children's Hospital: Allergy and Asthma Program, Boston
Study of Oral Food Challenge Biomarkers (SAFER)
RecruitingObservational study
- Boston Children's Hospital: Allergy and Asthma Program, Boston
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
RecruitingPhase 1Healthy volunteers welcome
- Massachusetts General Hospital, Boston
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
RecruitingPhase 2
- Massachusetts General Hospital, Boston
- Boston's Children's Hospital, Boston
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
RecruitingPhase 2
- Boston Children's Hospital, Boston
VE416 for Treatment of Food Allergy
RecruitingPhase 1/2
- Massachusetts General Hospital, Boston
Peanut Hypersensitivity trials in other cities
- Little Rock, AR6 studies
- Ann Arbor, MI6 studies
- Durham, NC4 studies
- New York City, NY4 studies
- Aurora, CO3 studies
- Cincinnati, OH3 studies
- Atlanta, GA3 studies
Other studies in Boston
- Breast Cancer110 studies
- Non-Small Cell Lung Cancer89 studies
- Cancer (all types)86 studies
- Metastatic Cancer63 studies
- Colorectal Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer61 studies
- Depression51 studies
- Endometrial Cancer50 studies
- Acute Myeloid Leukemia45 studies
- Pancreatic Cancer44 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.